Enhancing pathways to therapeutic development with clinical biomarkers.
Downing
Gregory J
GJ
Office of Science Policy and Planning, Office of Science Policy, Office of the Director, National Institutes of Health, Bethesda, MD, USA. gd34f@nih.gov
D000368:Aged; D015415:Biomarkers; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D004364:Pharmaceutical Preparations; D012107:Research Design
D015415:Biomarkers; D004364:Pharmaceutical Preparations